Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics study published in JAMA Oncology finds cumulative impact of paired DNA and RNA testing improves diagnostic yield and health equity.
Click here to view original post